A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters

PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel

Yong Zhang, Meirong Huo, Jianping Zhou et al. · Computer Methods and Programs in Biomedicine · 2010 · 2.1K citations

Pharmacy, Pharmacokinetics, Pharmacology +7

Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats

K.B.M. Saiful Islam, Satoru Fukiya, Masahito Hagio et al. · Gastroenterology · 2011 · 930 citations

Life Sciences, Microbiology, Physiology +16

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

Darrell S. Pardi, Edward V. Loftus, Walter K. Kremers et al. · Gastroenterology · 2003 · 563 citations · Full text

Medicine, Nutritional Sciences, Pharmacology +10

Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity

Tze Mun Loo, Fumitaka Kamachi, Yoshihiro Watanabe et al. · Cancer Discovery · 2017 · 471 citations

Life Sciences, Cancer Biology, Immunology +17

Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype

Clive R. Pullinger, Celeste Eng, Gerald Salen et al. · Journal of Clinical Investigation · 2002 · 469 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17